BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2008
View Archived Issues
Abbott identifies novel Tie-2 inhibitors active against cancer in preclinical studies
Read More
Trial demonstrates immunomodulating effects of COLD-fX
Read More
Medtronic commences U.S. and international Endeavor Resolute stent trials
Read More
Invitrogen and Biocare to market FDA approved SPOT-Light HER2 CISH Kit
Read More
Odanacatib suppresses bone resorption in breast cancer with established bone metastases
Read More
Threshold begins phase I/II study for TH-302 in patients with soft tissue sarcoma
Read More
Temoporfin improves tumoricidal depth in photodynamic therapy for bile duct cancer
Read More
Long-term safety for Diamyd vaccination in phase II autoimmune diabetes study
Read More
GSK and XenoPort submit NDA to FDA for Solzira in restless legs syndrome
Read More
Novavax tests seasonal influenza VLP vaccine candidate in phase II trial
Read More
Neuropharma changes name to Noscira, announces completion of phase I trials of NP-12
Read More
Priority review for Coartem
Read More
Compugen discovers peptide drug candidate for treatment of solid tumors
Read More
New therapeutic agents for HCV infection disclosed in recent patents
Read More
Recent patents report novel analgesic agents
Read More
New anti-HIV agents described in recent Myriad and Novartis patents
Read More
Mymetics achieves successful results in mucosal HIV/AIDS vaccine viral challenge
Read More
Myriad presents top-line results from phase I Vivecon trial
Read More
Clinical results of PANVAC-VF in metastatic breast cancer reported
Read More
China Biologic receives SFDA approval for human coagulation factor VIII trial
Read More
Depomed initiates phase III program for Gabapentin GR in menopausal hot flashes
Read More
DXL-625 shows superiority to Rituxan in animal studies
Read More
FDA approves expanded uses for Gardasil
Read More
Oramed initiates GLP1 analogue program with ORMD-0901
Read More
Davanat data filed for registration in late-stage colorectal cancer
Read More
Merck Serono commences ORACLE MS trial to evaluate Cladribine in MS
Read More
S*BIO initiates U.S. phase I trials of oral JAK2 inhibitor SB-1518
Read More